Report : Anatomic Pathology Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product and Service (Instruments, Consumables, and Services), Application (Disease Diagnosis, Drug Discovery and Development, and Others), and End User (Hospitals, Research Laboratories, Diagnostic Laboratories, and Others) and Geography
According to our latest study on “Anatomic Pathology Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product and Service, Application, and End User,” the market is projected to reach US$ 33,145.78 million by 2028 from US$ 21,488. 41 million in 2021; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market. The growth of the anatomic pathology market is primarily attributed to increase in the prevalence of cancer and other diseases, and growing focus on personalized medicines. However, the lack of skilled professionals and stringency of government regulations limit the growth of the market.
Based on product and service, the anatomic pathology market is segmented into instruments, consumables, and services. The services segment is expected to hold the largest share of the market In 2021, and it is further expected to register the highest CAGR during the forecast period. Services offered by any anatomical pathology laboratories include anatomical records, necropsy/deceased care center, cytopathology, electron microscopy, histopathology, immunopathology, and surgical pathology. Cytopathology service facilities offer service, training, and scientific work assistance. The laboratory service area handles the preparation, staining, and microscopic examination of patient samples. Histopathology processes include routine surgical tissue processing, embedding, microtomy, and cytochemical staining while preparing the sample for review by pathologists. The majority of cancers are diagnosed with the help of histopathology operations. Immunopathology-based diagnostic tests include autoimmune disease serologies, flow cytometry, immunohistochemistry, immunofluorescence microscopy, immunofixation, and high-resolution agarose electrophoresis. Surgical pathology labs receive all biopsy and surgical resection samples collected from patients, and the preliminary diagnosis involves examination of samples, followed by maintaining the laboratory information system. Anatomical pathology records help inform, transcribe, distribute, and archive final surgical pathology and autopsy reports. A surge in the prevalence of chronic diseases and increasing government support to develop advanced healthcare environments have created numerous potential opportunities for anatomical pathology service providers.
F. Hoffmann-La Roche AG, Danaher, Hologic, Inc, Agilent Technologies Inc, BioGenex, Diapath S.p.A, Bio SB, Merck KGaA, BD, and PHC Holdings Corporation are among the leading companies operating in the anatomic pathology market.
The anatomic pathology market is segmented based on product and service, application, and end user. Based on product and service, the anatomic pathology market is further segmented into instruments, consumables, and services. Based on application, the market has been subsegmented into disease diagnosis, drug discovery and development, and other applications. The anatomic pathology market, by end user, has been segmented into hospitals, research laboratories, diagnostic laboratories, and others.